{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T00:16:11Z","timestamp":1792368971088,"version":"4.4.0"},"reference-count":36,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2021,12,30]],"date-time":"2021-12-30T00:00:00Z","timestamp":1640822400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bpspubs.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Res &amp; Perspec"],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The novel coronavirus disease 2019 (COVID\u201019) emerged in late December 2019 in china and has rapidly spread to many countries around the world. The effective pharmacotherapy can reduce the mortality of COVID\u201019. Antiviral medications are the candidate therapies for the management of COVID\u201019. Molnupiravir is an antiviral drug with anti\u2010RNA polymerase activity and currently is under investigation for the treatment of patients with COVID\u201019. This review focuses on summarizing published literature for the mechanism of action, safety, efficacy, and clinical trials of molnupiravir in the treatment of COVID\u201019 patients.<\/jats:p>","DOI":"10.1002\/prp2.909","type":"journal-article","created":{"date-parts":[[2021,12,30]],"date-time":"2021-12-30T08:59:37Z","timestamp":1640854777000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":108,"title":["Molnupiravir: A new candidate for COVID\u201019 treatment"],"prefix":"10.1002","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0026-9734","authenticated-orcid":false,"given":"Fariba","family":"Pourkarim","sequence":"first","affiliation":[{"name":"Student Research Committee Faculty of Pharmacy Tabriz University of Medical Sciences  Tabriz Iran"},{"name":"Department of Clinical Pharmacy Faculty of Pharmacy Tabriz University of Medical Sciences  Tabriz Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samira","family":"Pourtaghi\u2010Anvarian","sequence":"additional","affiliation":[{"name":"Student Research Committee Faculty of Pharmacy Tabriz University of Medical Sciences  Tabriz Iran"},{"name":"Department of Clinical Pharmacy Faculty of Pharmacy Tabriz University of Medical Sciences  Tabriz Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haleh","family":"Rezaee","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy Faculty of Pharmacy Tabriz University of Medical Sciences  Tabriz Iran"},{"name":"Infectious Diseases and Tropical Medicine Research Center Tabriz University of Medical Sciences  Tabriz Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,12,30]]},"reference":[{"key":"e_1_2_14_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25678"},{"key":"e_1_2_14_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30183-5"},{"key":"e_1_2_14_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30211-7"},{"key":"e_1_2_14_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30185-9"},{"key":"e_1_2_14_6_1","doi-asserted-by":"publisher","DOI":"10.34172\/PS.2020.41"},{"key":"e_1_2_14_7_1","unstructured":"World Health OrganizationCoronavirus disease (COVID\u201019) situation dashboard. CEST. Accessed December 23 2021.https:\/\/covid19.who.int"},{"key":"e_1_2_14_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.705"},{"key":"e_1_2_14_9_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2020.25.3.2000045"},{"key":"e_1_2_14_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe2001329"},{"key":"e_1_2_14_11_1","unstructured":"National Center for Health Statistics & Centers for Disease Control and Prevention.COVID\u201019 data from the National Center for Health Statistics.2020. Accessed April 1 2020.https:\/\/www.cdc.gov\/coronavirus\/2019\u2010ncov\/symptoms\u2010testing\/symptoms.html"},{"key":"e_1_2_14_12_1","doi-asserted-by":"publisher","DOI":"10.7326\/M20-2428"},{"key":"e_1_2_14_13_1","unstructured":"World Health OrganizationCoronavirus disease (COVID\u201019) weekly epidemiological update.2020. Accessed August 24 2020.https:\/\/www.who.int\/docs\/default\u2010source\/coronaviruse\/situation\u2010reports\/20200824\u2010weekly\u2010epi\u2010update.pdf?sfvrsn=806986d1_4"},{"key":"e_1_2_14_14_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-020-0695-z"},{"key":"e_1_2_14_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.14124"},{"key":"e_1_2_14_16_1","doi-asserted-by":"publisher","DOI":"10.1159\/000507423"},{"key":"e_1_2_14_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2021.103595"},{"key":"e_1_2_14_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2019.12.002"},{"key":"e_1_2_14_19_1","doi-asserted-by":"publisher","DOI":"10.1080\/13543776.2021.1880568"},{"key":"e_1_2_14_20_1","doi-asserted-by":"publisher","DOI":"10.1021\/acs.oprd.1c00033"},{"key":"e_1_2_14_21_1","article-title":"The combined treatment of Molnupiravir and Favipiravir results in a marked potentiation of efficacy in a SARS\u2010CoV2 hamster infection model through an increased frequency of mutations in the viral genome","author":"Abdelnabi R","year":"2021","journal-title":"bioRxiv"},{"key":"e_1_2_14_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature02145"},{"key":"e_1_2_14_23_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.79.23.14614-14621.2005"},{"key":"e_1_2_14_24_1","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20150256"},{"key":"e_1_2_14_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrg2323"},{"key":"e_1_2_14_26_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12985-020-01415-w"},{"key":"e_1_2_14_27_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03312-w"},{"key":"e_1_2_14_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2020.111887"},{"key":"e_1_2_14_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2020.101992"},{"key":"e_1_2_14_30_1","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02428-20"},{"key":"e_1_2_14_31_1","article-title":"Human safety, tolerability, and pharmacokinetics of a novel broad\u2010spectrum oral antiviral compound, molnupiravir, with activity against SARS\u2010CoV\u20102","author":"Painter WP","year":"2020","journal-title":"medRxiv"},{"key":"e_1_2_14_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2021.102329"},{"key":"e_1_2_14_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.100867"},{"key":"e_1_2_14_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111642"},{"key":"e_1_2_14_35_1","doi-asserted-by":"publisher","DOI":"10.1124\/molpharm.121.000333"},{"key":"e_1_2_14_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-020-00835-2"},{"key":"e_1_2_14_37_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22580-8"}],"container-title":["Pharmacology Research &amp; Perspectives"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/prp2.909","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/prp2.909","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/prp2.909","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T16:33:54Z","timestamp":1692981234000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1002\/prp2.909"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,30]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["10.1002\/prp2.909"],"URL":"https:\/\/doi.org\/10.1002\/prp2.909","archive":["Portico"],"relation":{"has-preprint":[{"id-type":"doi","id":"10.22541\/au.170666417.79795010\/v1","asserted-by":"object"}]},"ISSN":["2052-1707","2052-1707"],"issn-type":[{"value":"2052-1707","type":"print"},{"value":"2052-1707","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,12,30]]},"assertion":[{"value":"2021-06-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-15","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-30","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00909"}}